

ADVANCED OXYGEN THERAPY INC
AOTI’s TWO2 therapy is clinically proven to heal chronic wounds, reducing hospitalizations and amputations while improving quality of life and reducing costs. As an at-home therapy, TWO2 improves patient access and compliance. Our NEXA NPWT offers simplicity, performance and affordability.
Oceanside, California, United States
Healthcare
Products & Services
People
Products & Services
TWO2 Multi-Patch
Advanced Oxygen Therapy Inc
Multi-Patch is indicated for use on acute or chronic wounds*
The recommended Multi-Patch treatment is 60 minutes, 4-7 days per week.**
*Prescribers may determine alternative frequency or duration depending on an individual patient’s medical needs
**Please contact your local AOTI representative if it is available in your country.
The recommended Multi-Patch treatment is 60 minutes, 4-7 days per week.**
*Prescribers may determine alternative frequency or duration depending on an individual patient’s medical needs
**Please contact your local AOTI representative if it is available in your country.
TWO2 Extremity Chamber
Advanced Oxygen Therapy Inc
The Extremity Chamber is available in two sizes, large and medium. The medium chamber easily accommodates wounds on the lower two thirds of the leg. Meanwhile, the larger chamber is designed to fit over the patient’s knee, allowing treatment of larger limbs and venous leg ulcers (VLUs). The chamber can be used in conjunction with either conventional compression dressings (CCD) or UNNA boots. The chamber can also be used over total contact casts (TCC) when treating diabetic foot ulcers (DFUs).
NEXA™ NPWT System
Advanced Oxygen Therapy Inc
AOTI’s NEXA™ NPWT System uses an innovative technology platform that has enabled the development of a multi-week, multi-patient, disposable Negative Pressure Wound Therapy (NPWT) system that delivers many performance features of durable devices, while providing the flexibility benefits of disposable systems.
People
Add Attachment

Share
Recent Chats
Share via email
Future: handle WhatsApp here
Future: handle LinkedIn here
Future: handle Twitter here
SUBMENU HERE
Share via Chat
Copy Link